Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia

Eugene Han, Yujung Yun, Gyuri Kim, Yong Ho Lee, Hye Jin Wang, byungwan lee, Bong Soo Cha, Beom Seok Kim, Eun Seok Kang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0%) patients did not experience renal function loss, and 125 (36.3%) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation.

Original languageEnglish
Article numbere0154683
JournalPLoS One
Volume11
Issue number5
DOIs
Publication statusPublished - 2016 May 1

Fingerprint

diabetic nephropathy
hypertriglyceridemia
Hypertriglyceridemia
Omega-3 Fatty Acids
Diabetic Nephropathies
Medical problems
omega-3 fatty acids
diabetes
renal function
Kidney
filtrates
dosage
creatinine
albumins
Albumins
Creatinine
urine
Urine
Albuminuria
kidney diseases

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Han, Eugene ; Yun, Yujung ; Kim, Gyuri ; Lee, Yong Ho ; Wang, Hye Jin ; lee, byungwan ; Cha, Bong Soo ; Kim, Beom Seok ; Kang, Eun Seok. / Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. In: PLoS One. 2016 ; Vol. 11, No. 5.
@article{0dcdb23eee7d4a71bc8f95ff32a1c4be,
title = "Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia",
abstract = "Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0{\%}) patients did not experience renal function loss, and 125 (36.3{\%}) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation.",
author = "Eugene Han and Yujung Yun and Gyuri Kim and Lee, {Yong Ho} and Wang, {Hye Jin} and byungwan lee and Cha, {Bong Soo} and Kim, {Beom Seok} and Kang, {Eun Seok}",
year = "2016",
month = "5",
day = "1",
doi = "10.1371/journal.pone.0154683",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. / Han, Eugene; Yun, Yujung; Kim, Gyuri; Lee, Yong Ho; Wang, Hye Jin; lee, byungwan; Cha, Bong Soo; Kim, Beom Seok; Kang, Eun Seok.

In: PLoS One, Vol. 11, No. 5, e0154683, 01.05.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia

AU - Han, Eugene

AU - Yun, Yujung

AU - Kim, Gyuri

AU - Lee, Yong Ho

AU - Wang, Hye Jin

AU - lee, byungwan

AU - Cha, Bong Soo

AU - Kim, Beom Seok

AU - Kang, Eun Seok

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0%) patients did not experience renal function loss, and 125 (36.3%) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation.

AB - Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0%) patients did not experience renal function loss, and 125 (36.3%) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation.

UR - http://www.scopus.com/inward/record.url?scp=84967163420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967163420&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0154683

DO - 10.1371/journal.pone.0154683

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0154683

ER -